Pseudoprogression after glioma therapy: a comprehensive review

Magnetic resonance (MR) perfusion imaging to differentiate early progression from pseudoprogression following chemoradiotherapy for glioblastoma (GBM).

(2017) J. J. Graber et al.   JOURNAL OF CLINICAL ONCOLOGY

Pseudoprogression Following Chemoradiotherapy for Glioblastoma Multiforme

(2014) Paul Sanghera et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Comparison of F-18 FDG and C-11 Methionine PET/CT for the Evaluation of Recurrent Primary Brain Tumors

(2012) Madhavi Tripathi et al.   CLINICAL NUCLEAR MEDICINE

Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival

(2012) Seymur Gahramanov et al.   RADIOLOGY

Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status

(2011) D.-S. Kong et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Treatment-Related Change Versus Tumor Recurrence in High-Grade Gliomas: A Diagnostic Conundrum—Use of Dynamic Susceptibility Contrast-Enhanced (DSC) Perfusion MRI

(2011) Girish M. Fatterpekar et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

(2011) M. Wardak et al.   CLINICAL CANCER RESEARCH

The Concepts, Diagnosis and Management of Early Imaging Changes after Therapy for Glioblastomas

(2011) P. Sanghera et al.   CLINICAL ONCOLOGY

F-18 FDG PET-CT in patients with recurrent glioma: Comparison with contrast enhanced MRI

(2011) Amburanjan Santra et al.   EUROPEAN JOURNAL OF RADIOLOGY

Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma

(2011) Xintao Hu et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: A retrospective analysis

(2011) Ashray Gunjur et al.   Journal of Medical Imaging and Radiation Oncology

Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression

(2011) Nadia Malkoun et al.   JOURNAL OF NEURO-ONCOLOGY

Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion

(2011) J. Narang et al.   NEURO-ONCOLOGY

Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma

(2011) R. J. Young et al.   NEUROLOGY

Improved Perfusion MR Imaging Assessment of Intracerebral Tumor Blood Volume and Antiangiogenic Therapy Efficacy in a Rat Model with Ferumoxytol

(2011) Seymur Gahramanov et al.   RADIOLOGY

Distinguishing Recurrent Primary Brain Tumor from Radiation Injury: A Preliminary Study Using a Susceptibility-Weighted MR Imaging−Guided Apparent Diffusion Coefficient Analysis Strategy

(2010) A. Al Sayyari et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States

(2010) S. A. Grossman et al.   CLINICAL CANCER RESEARCH

Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide

(2010) Emel Yaman et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI

(2010) Yong Hwy Kim et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Favorable Prognosis in Patients With High-Grade Glioma With Radiation Necrosis: The University of Colorado Reoperation Series

(2010) Kyle E. Rusthoven et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Potential for Differentiation of Pseudoprogression From True Tumor Progression With Dynamic Susceptibility-Weighted Contrast-Enhanced Magnetic Resonance Imaging Using Ferumoxytol vs. Gadoteridol: A Pilot Study

(2010) Seymur Gahramanov et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System

(2010) Victor A. Levin et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Parametric Response Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma

(2010) Christina Tsien et al.   JOURNAL OF CLINICAL ONCOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53

(2010) Hyun-Cheol Kang et al.   JOURNAL OF NEURO-ONCOLOGY

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients

(2010) C.-K. Park et al.   NEURO-ONCOLOGY

Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas

(2009) Deok-Joo Rhee et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma

(2009) Jennifer L. Clarke et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression

(2009) Elizabeth R. Gerstner et al.   JOURNAL OF NEURO-ONCOLOGY

The parametric response map is an imaging biomarker for early cancer treatment outcome

(2009) Craig J Galbán et al.   NATURE MEDICINE

Therapeutic Advances in Malignant Glioma: Current Status and Future Prospects

(2009) H. Ian Robins et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Distinction between glioma progression and post-radiation change by combined physiologic MR imaging

(2009) Eiji Matsusue et al.   NEURORADIOLOGY

FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme

(2009) M. H. Cohen et al.   ONCOLOGIST

Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations

(2009) Cristo Chaskis et al.   SURGICAL NEUROLOGY

Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements

(2008) L.S. Hu et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

(2008) Walter Taal et al.   CANCER

Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis?

(2008) C. Peca et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: Initial experience

(2008) Carlos J. Ledezma et al.   EUROPEAN JOURNAL OF RADIOLOGY

MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

(2008) Alba A. Brandes et al.   JOURNAL OF CLINICAL ONCOLOGY

The positive predictive value of O-(2-[18F]fluoroethyl)-l-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment

(2008) J. H. Mehrkens et al.   JOURNAL OF NEURO-ONCOLOGY

Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy

(2008) Y. Terakawa et al.   JOURNAL OF NUCLEAR MEDICINE

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

(2008) Alba A. Brandes et al.   NEURO-ONCOLOGY

Postoperative Treatment of Primary Glioblastoma Multiforme With Radiation and Concomitant Temozolomide in Elderly Patients

(2007) Stephanie E. Combs et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS